| Overcoming skin barriers through advanced transdermal drug delivery approaches V Phatale, KK Vaiphei, S Jha, D Patil, M Agrawal, A Alexander Journal of controlled release 351, 361-380, 2022 | 236 | 2022 |
| Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer R Sharma, V Yadav, S Jha, S Dighe, S Jain Carbohydrate Polymers 338, 122196, 2024 | 9 | 2024 |
| Antiproliferative activity of syringic acid-loaded nanostructured lipid carriers against MCF-7 human breast carcinoma cells. S Jha, A Prabakaran, RK Sahoo, S Batheja, U Gupta, A Alexander Journal of Drug Delivery Science and Technology, 105902, 2024 | 4 | 2024 |
| Hepatocellular carcinoma: Preclinical and clinical applications of nanotechnology with the potential role of carbohydrate receptors S Batheja, RK Sahoo, S Tarannum, KK Vaiphei, S Jha, A Alexander, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1867 (10), 130443, 2023 | 3 | 2023 |
| Plant-based therapeutics: current status and future perspectives S Jha, KK Vaiphei, A Alexander Phytopharmaceuticals and Herbal Drugs, 3-11, 2023 | 3 | 2023 |
| Advancing apoptosis induction in triple negative breast cancer: Empowering treatment with tyrosine-stapled mixed micelles of lapatinib R Ghadi, A Wadikar, M Dharshini, V Yadav, K Kuche, T Date, ... Journal of Molecular Liquids 401, 124635, 2024 | 2 | 2024 |
| Ferroptosis: Molecular Perspective, Cellular Influence, Cancer Manifestation And Therapeutic Potentials PK Pandey, S Bhorkade, S Jha, BN Saren, K Kuche, S Jain Journal of Drug Delivery Science and Technology, 105998, 2024 | 1 | 2024 |
| Unveiling the Potential of Nanosuspension Formulation Strategy for Improved Oral Bioavailability of Gefitinib P Sayyad, S Jha, R Sharma, V Yadav, S Jain AAPS PharmSciTech 26 (2), 59, 2025 | | 2025 |